March 29, 2019

Research Highlights

Read how Osbourne, et al. has used our AAV services to test the neuroprotective efficacy of a novel gene therapy construct.
March 29, 2019

Nature Article Series

We have partnered with Nature to create an article series that highlights gene therapy production strategies and technologies.
December 18, 2018

Vigene Biosciences announces partnership with Viro...

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the […]
September 18, 2018

Nature Article Series: Insect Virus Latest Ally in...

Vigene has partnered with Nature to create a four-part series of articles highlighting production strategies and technologies that are being […]
September 18, 2018

Nature Article Series: A Helping Hand for Gene The...

Vigene has partnered with Nature to create a four-part series of articles highlighting production strategies and technologies that are being […]
August 15, 2018

Vigene Biosciences Ranks 81st on the 2018 Inc. 500...

ROCKVILLE, Md. Inc. magazine today revealed that Vigene Biosciences is No. 81 on its 37th annual Inc. 5000, the most prestigious […]
July 19, 2018

Nature Article Series: Three is the Magic Number i...

Vigene has partnered with Nature to create a four-part series of articles highlighting production strategies and technologies that are being […]
May 29, 2018

Vigene Biosciences Named Emerging Growth Company o...

ROCKVILLE, Md. Vigene Biosciences, Inc. has been recognized as the 2018 Emerging Growth Company of the Year by ACG National […]
January 14, 2018

Nature Article Series: Growing Pains for Gene Ther...

Vigene has partnered with Nature to create a four-part series of articles highlighting new production strategies and technologies that are […]
November 7, 2017

Vigene Biosciences Partners with The Michael J. Fo...

ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, today announced a […]